Yaohai Biopharmaceutical Co., Ltd. (abbreviatedly called Yaohai Bio-Pharma) was founded in August 2010.
It has served as a CRDMO (Contract, Research, Development, and Manufacturing Organization) specializing in microbial expression systems and offering one-stop services, including microbial strain engineering, microbial cell banking, process development, analysis and testing, and large-scale and cGMP-guided manufacturing of clinical samples and commercial products, etc.
Since its establishment, we have been focusing on “recombinant protein/polypeptides, mRNA/plasmids, nanobodies, novel recombinant vaccines, and others” for human, veterinary, and pet health management.
From DNA to drug products for clinical and commercial supply.
Dedicated to providing CRDMO solution for global clients
No self-developed pipelines
200+ CRDMO projects delivered
300+ genetically engineered microbial strain
Recombinant protein yield up to 15 g/L
Custom strains including but not limited to Escherichia coli and yeast.
Custom biologics including DNA/RNA, peptides, enzymes, vaccines, etc.
Custom processes including soluble and insoluble forms.
Yaohai Biology focuses on microbial expression system CDMO service provider, which can provide one-stop biologic medicine end-to-end service for global customers.
Copyright © Yaohai Biopharmaceutical Co., Ltd. All Rights Reserved | Privacy Policy
EN
